21/06/2018. MEASURING PERFORMANCE (AUDIT AND QUALITY IMPROVEMENT) Towards Reducing Inequity. What should we be measuring?
|
|
- Veronica Hawkins
- 5 years ago
- Views:
Transcription
1 MEASURING PERFORMANCE (AUDIT AND QUALITY IMPROVEMENT) Towards Reducing Inequity Dr Raewyn Fisher Cardiologist Director of Waikato Integrated Heart Failure Service What should we be measuring? At risk, prevention Incidence, diagnosis Therapy (incl. drugs, devices) Hospitalisation Outcome, re-admission, mortality. Continuum of disease Are we measuring the right things? Hospitalisation data = Stage C-D heart failure Underestimates true incidence/prevalence/burden Missing opportunities to prevent and delay disease progression Copyright American Heart Association 1
2 What do we know from NZ data? What we do know from Midland data Number of HF admissions are increasing (>1700/yr) Number of HF patients are increasing Highest number are elderly Higher rate in Maori/Pacific 5x rate in Maori/Pacific aged yrs Highest rates and number in most deprived areas What we do know from Midland data What we do know from Midland data Constant and significant re-admission rate 25% 1 year re-admission Higher rate with elderly Higher rate with high deprivation No re-adm difference with LOS No re-adm difference with ethnicity Primary care prevalence = Secondary care prevalence Maori/Pacific rate consistently > non M/P at all ages Consistently higher rate with higher levels of deprivation 2
3 What is our target HF population? Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals Nathalie Conrad, MSc, Prof Andrew Judge, PhD, Jenny Tran, MSc, Hamid Mohseni, PhD, Deborah Hedgecott, BSc, Abel Perez Crespillo, BSc, Moira Allison, BSc, Prof Harry Hemingway, FRCP, Prof John G Cleland, MD, Prof John J V McMurray, MD, Prof Kazem Rahimi, FRCP The Lancet Volume 391, Issue 10120, Pages (February 2018) DOI: /S (17) Findings From 2002 to 2014, heart failure incidence (standardised by age and sex) decreased, similarly for men and women, by 7% (from 358 to 332 per person-years; adjusted HF incidence 7% decrease incidence ratio 0 93, 95% CI ). However, the estimated absolute number of individuals with newly New diagnosed HF pts heart failure in 12% the UK increased by 12% (from in 2002 to HF in 2014), prevalence largely due to an increase 23% increase population size and age. The estimated absolute number of prevalent heart failure cases in the UK increased even more, by 23% (from to ). Over the study period, patient age and multimorbidity at first presentation of heart failure increased (mean age 76 5 years [SD 12 0] to 77 0 years [12 9], adjusted difference 0 79 years, 95% CI ; mean number of comorbidities 3 4 [SD 1 9] vs 5 4 [2 5]; adjusted difference 2 0, 95% CI ). Age at 1 st presentation Slight increase Socioeconomically deprived individuals were more likely to develop heart failure than were affluent Co-morbidities individuals (incidence rate ratio 1 61, Increase 95% CI ), 3.4 to 5.4 and did so earlier in life than Socio-economic those from the most affluent gap group (adjusted Widened difference 3 51 years, 95% CI 3 77 to 3 25). From 2002 to 2014, the socioeconomic gradient in age at first presentation with heart failure widened. Socioeconomically deprived individuals also had more comorbidities, despite their younger age. Temporal trends in age at diagnosis of incident heart failure by socioeconomic status quintile ( ) 3
4 Focusing our resources Upping our game with Diagnosis and Treatment You re suffering from a terrible post-code Younger /prevention vs Older/multi-morbid HF patients aren t all the same But common investigation/therapy/management Patient journey + Clinical pathways Agree on pathway Implement pathway Audit pathway adherence Resource the pathway 4
5 NICE Pathway Chronic heart failure Implementing NICE guidance The NICE chronic heart failure pathway covers the diagnosis and management of chronic heart failure in adults in primary and secondary cares NICE clinical guideline 108 NZ Cardiac Network recommendations for referral and access to secondary care for common cardiac conditions Cardiology referral not necessarily appropriate, for patients consider in whom declining intervention referral. by secondary care will influence management Cardiology referral appropriate Auditable standard. All patients should have an assessment, initial investigation and management plan within 4 months of referral. Priority for more urgent assessment is expected. Indication for an echocardiogram with a verified report from an accredited cardiologist or CSANZ level 1 trained physician) Non Acute Chest Pain Suspected Heart Failure Patients with low cardiovascular risk and atypical symptoms Patients with symptoms consistent with angina regardless of CV risk Patients with uncertain symptoms and increased 1. cardiovascular Ensure that referred risk patients where appropriate have been adequately assessed with either non-invasive testing to a level that can satisfactorily rule out prognostic coronary artery disease or referred for invasive angiography 2. Perform above within an audited clinical governance structure that includes Acute an Chest accredited Pain cardiologist. All patients presenting with possible acute coronary syndrome 1. Assess with an accelerated chest pain pathway 2. 70% of appropriate patients admitted with acute coronary syndrome receive angiography within 3 days Confirmed ST elevation myocardial infarction 1. Primary percutaneous intervention if it can be reliably delivered within 120 minutes from first medical contact 2. In patients who cannot receive timely primary percutaneous intervention thrombolysis as soon as possible unless contraindicated 3. When rescue percutaneous intervention would be considered in the event of failed thrombolysis the patient should be transferred immediately to a PCI If LV function centre not known to assess left ventricular function in all patients with ACS. To occur before discharge in all patients at higher risk Secondary Prevention for IHD Primary and Secondary Care are expected to work together to provide a community and evidence based prevention programme tailored to individual needs and geographic location for patients with ACS Patients with non-limiting symptoms and normal cardiac biomarkers (when not on treatment), normal ECG and normal chest X-ray Symptomatic patients with elevated cardiac biomarkers, abnormal Chest X-ray or ECG Timely assessment including early echocardiography A clinical governance structure that includes a multidisciplinary heart failure service Optimisation of Heart Failure medication phase: at the end of (approx. 3 months) the titration phase, post revascularisation and or post MI when initial EF suspected to be <35% in order to determine future management including device implantation. Follow up: if change in clinical status or cardiac exam Baseline and serial re-evaluation in a patient undergoing therapy with cardiotoxic agents Atrial Fibrillation Patients with uncomplicated AF and clearly defined embolic risk Rhythm control or cardioversion is considered Heart rate not adequately controlled, ongoing symptoms, or treatment intolerance Abnormal resting ECG (other than AF) or significant finding on echocardiogram Echocardiography appropriate for 1. New diagnosis of atrial fibrillation 2. Change in clinical status 3. Suspected underlying structural heart disease or LV dysfunction Access to cardiology assessment, appropriate investigation and evidence based treatment within an appropriate time frame Palpitations /syncope/arrhythmia Patients with infrequent symptoms non-limiting symptoms and low probability of cardiac disease Symptoms consistent with sustained tachycardia Syncope consistent with cardiac cause Exercise induced pre syncope/palpitations Access to cardiology assessment, appropriate investigation and treatment within an appropriate time frame Echocardiography for suspected valve/ structural /inherited/ heart disease A persistent heart murmur which Cannot be explained by fever, anaemia, high output, pregnancy. Is associated with new or changing symptoms Is associated with a raised BNP, abnormal ECG or Chest X-ray Screening of first-degree relatives for inherited Follow-up cardiomyopathy Echocardiography for known heart valve disease Monitoring for potential treatment related cardiotoxicity Valve pathology Aortic/Mitral regurgitation Aortic Stenosis Mild Moderate Severe Not necessary Vmax m/s 3-5 years 1-2 years 6/12-1 y Vmax m/s 1-2 years Vmax > 4.0 m/s 6/12-1 y MVA > cm2 < 1.0 cm2 Mitral cm2 1-2 years 1y Stenosis Follow up 3-5 echocardiography years for prosthetic valves Bioprosthetic Mechanical < 2y not necessary <3y not necessary 2-3y for first 10y then annually 3-5y Repaired Log of echocardiographic <5y not activity 5y collected line with these standards necessary NZ Cardiac Network recommendations for referral and access to secondary care for common cardiac conditions for patients in whom intervention by secondary care will influence management Cardiology referral not necessarily appropriate, consider declining referral. Cardiology referral appropriate Auditable standard. All patients should have an assessment, initial investigation and management plan within 4 months of referral. Priority for more urgent assessment is expected. Indication for an echocardiogram with a verified report from an accredited cardiologist or CSANZ level 1 trained physician) Suspected Heart Failure Patients with non-limiting symptoms and normal cardiac biomarkers (when not on treatment), normal ECG and normal CXR Symptomatic patients with elevated cardiac biomarkers, abnormal Chest X-ray or ECG Timely assessment including early echocardiography A clinical governance structure that includes a multi-disciplinary heart failure service Optimisation of Heart Failure medication phase: at the end of (approx. 3 months) the titration phase, post revascularisation and or post MI when initial EF suspected to be <35% in order to determine future management including device implantation. Follow up: if change in clinical status or cardiac exam Baseline and serial re-evaluation in a patient undergoing therapy with cardiotoxic agents 5
6 Focusing our resources on earlier stages of HF Identify at risk Timely and correct diagnosis Pt awareness GP access BNP + signs/symptoms Access to diagnostics and expert care BPAC etc Audit Electronic Medicine Focusing our resources on management Appropriate evidence based Rx Prescription, dispensing and adherence Longterm Rx Dosage/uptitration Updating Rx, devices Palliative care 6
7 The Message Prescribe evidence based therapies unless contra-indicated ACE/ARB + BB : IF NOT, WHY NOT? Up-titrate therapy to maximum tolerated Titration Guidelines for CNS Beta-blockers ACE inhibitors/arbs Diuretics Monitor Rx (and CV risks) regularly MRA s Device Therapy for HF Relative contra-indications = K+ > 5 Creat > 221 egfr < 30 7
8 MEASURING MANAGEMENT OUTCOMES 2018 REGISTRY DATA COMPLETION REG NO. BRIEF FORM DATA TRENDS OVER TIME BRIEF VS FULL FORMS BRIEF 2016 FULL %HFrEF BB ACE/ARB MRA 0 NUMBER %HFrEF BB ACE/ARB MRA BRIEF FORM PTS : LOWER IN-HOSPITAL DEATH AND SHORTER LOS 8
9 MIDLAND VS NATIONAL THAMES/COROMANDEL N=363 referred N=162 HFrEF MIDLAND NATIONAL N=116 with repeat echo 20 0 %FULL FORM %HFrEF BB ACE/ARB MRA N=65 (56%) EF improved N=34 (29%) EF stable N=17 (15%) EF worsened (2016 FULL FORM DATA) 36 FOR DISCUSSION FOCUSING RESOURCE Know what resource we have (and don t have) Questions??? MEASURING OUTCOMES HF Management rather than hospital admissions/discharges IMPROVED CARE, REDUCED INEQUITY COMMUNITY/PRIMARY CARE INTERFACE Earlier diagnosis, appropriate management 9
REGIONAL DIFFERENCES IN HF SERVICE DEMAND AND DELIVERY
REGIONAL DIFFERENCES IN HF SERVICE DEMAND AND DELIVERY Raewyn Fisher, Waikato Hospital On behalf of Midland Cardiac Network (With thanks to Population Health data analysts) Cardiac Network Plans (Midland)
More information8 th BSH Heart Failure Nurse and Healthcare Professional Study Day 2018
8 th BSH Heart Failure Nurse and Healthcare Professional Study Day 2018 Presentation title: What is new in heart failure for 2018? Speaker: Geraint Morton MA MBBS MRCP PhD Conflicts of interest: Nil relevant
More informationDr Gerry Devlin. Dr Fraser Hamilton. Medical Director National Heart Foundation. General Practitioner Heart Foundation
Dr Gerry Devlin Medical Director National Heart Foundation Dr Fraser Hamilton General Practitioner Heart Foundation 8:30-9:25 WS #72: Controversies in Cardiovascular Disease 9:35-10:30 WS #82: Controversies
More information7. Echocardiography Appropriate Use Criteria (by Indication)
Criteria for Echocardiography 1133 7. Echocardiography Criteria (by ) Table 1. TTE for General Evaluation of Cardiac Structure and Function Suspected Cardiac Etiology General With TTE 1. Symptoms or conditions
More information1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare?
1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare? Dr Nerys Davies, GPST Ms B. Davies, Specialist Nurse (Heart Failure) Dr J. Taylor, Consultant Cardiologist
More informationArrhythmia Care in the DGH What Still Needs to be Done? Dr. Sundeep Puri Consultant Cardiologist
Arrhythmia Care in the DGH What Still Needs to be Done? Dr. Sundeep Puri Consultant Cardiologist LOTS!!! This presentation confines itself to the situation in the North West. The views expressed are my
More informationNCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT
NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT CONTENTS PATIENTS ADMITTED WITH HEART FAILURE...4 Demographics... 4 Trends in Symptoms... 4 Causes and Comorbidities
More informationDr Joan Leighton. Professor Gerry Devlin. 14:00-14:55 WS #106: Whats Topical in Cardiology 15:05-16:00 WS #116: Whats Topical in Cardiology (Repeated)
Professor Gerry Devlin Clinical Cardiologist and Interventional Cardiologist NZ Heart Foundation Hamilton Dr Joan Leighton General Practitioner Heart Foundation Christchurch 14:00-14:55 WS #106: Whats
More informationASE 2011 Appropriate Use Criteria for Echocardiography
ASE 2011 Appropriate Use Criteria for Echocardiography Table 1. TTE for General Evaluation of Cardiac Structure and Function 1 2 Suspected Cardiac Etiology General With TTE Symptoms or conditions potentially
More informationWhen Should I Order a Stress Test or an Echocardiogram
When Should I Order a Stress Test or an Echocardiogram Updates in Cardiology 2015 March 7, 2015 Donald L. Lappé, MD, FAHA, FACC Chairman, Cardiovascular Department Medical Director, Intermountain Cardiovascular
More informationSevere Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes
Severe Hypertension *Prior to making a referral, call office or Doc Halo, to speak with a Cardiologist or APP to discuss patient and possible treatment options. Please only contact the patient's cardiologist.
More informationDiagnosis and management of Chronic Heart Failure in 2018: What does NICE say? PCCS Meeting Issues and Answers Conference Nottingham
Diagnosis and management of Chronic Heart Failure in 2018: What does NICE say? PCCS Meeting Issues and Answers Conference Nottingham NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Chronic heart failure
More informationThe more we listen, the more lives we save. Heart Valve V O I C E. Heart Valve Disease. A Practical Guide for Primary Care
Heart Valve V O I C E The more we listen, the more lives we save. Heart Valve Disease A Practical Guide for Primary Care About Heart Valve Voice Heart Valve Voice is a charity run by a group of multi-disciplinary
More informationEvaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography
Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography Rebecka Karlsson Pardeep Jhund 1 Material and methods
More informationNHS QIS National Measurement of Audit Acute Coronary Syndrome
NHS QIS National Measurement of Audit Acute Coronary Syndrome Things have changed based on the experience and feedback from the first cycle of measurement and, for the better we think! The Acute Coronary
More informationNew NICE Heart Failure Guidelines What do they mean for primary and secondary care, and patients?
New NICE Heart Failure Guidelines 2018 - What do they mean for primary and secondary care, and patients? Prof Ahmet Fuat PhD FRCGP FRCP PG Dip (Cardiology) GP & GPSI Cardiology Darlington Professor of
More informationHeart Failure A Disease for the Internist?
Heart Failure A Disease for the Internist? Dr Chris Davidson Sussex Cardiac Centre BRIGHTON UK Hot Topics in Heart Failure Drug treatments Valsartan / neprilysin inhib Investigations BNP and others Devices
More informationClinical Indications for Echocardiography
Clinical Indications for Echocardiography Echocardiography is widely utilised and potential applications are increasing with advances in technology. The aim of this document is two-fold: 1) To define clinical
More informationHeart Failure in 2012 with reference to NICE Guidance Dr Maurice Pye Consultant Cardiologist York District Hospital
Heart Failure in 2012 with reference to NICE Guidance 2010 Dr Maurice Pye Consultant Cardiologist York District Hospital A little over elaborate,do not include ECG or CXR If clinical suspicion is high
More informationESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Patients t with acute heart failure frequently develop chronic heart failure Patients with chronic heart failure frequently decompensate acutely ESC Guidelines for the Diagnosis and A clinical response
More informationBritish Cardiac Society. Clinical and laboratory cardiac facilities required in the UK
Page 1 of 15 British Cardiac Society Clinical and laboratory cardiac facilities required in the UK David Hackett Professional Standards & Peer Review Committee December 2004 Summary: Clinical cardiac facilities
More informationAssociate Professor Gerry Devlin
Associate Professor Gerry Devlin Clinical Cardiologist and Interventional Cardiologist NZ Heart Foundation Hamilton 9:00-9:15 Secondary Prevention of IHD The Challenge of Secondary Prevention Associate
More informationHeart Failure Acute and Chronic
Heart Failure Acute and Chronic Cardiac Services in Wales Acute Heart Failure standards Chronic Heart Failure standards NWIS admissions/readmission data NHFA data 2016-17 Echo accessibility BNP availability
More informationCongestive Heart Failure or Heart Failure
Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Myocardial infarction: secondary prevention in primary and secondary care for patients following a myocardial infarction 1.1
More informationST3 ST4 ST5 ST6 ST7 ALS
2010 Cardiology (amendments 2016) ARCP Decision Aid The table that follows includes a column for each training year which documents the targets that have to be achieved for a ARCP outcome at the end of
More informationThe National Heart Failure Audit 2010/2011
The National Heart Failure Audit 2010/2011 Project Steering Group; TA McDonagh, JG Cleland, HJ Dargie, S Hardman,P Mitchell, A Cunningham 85% NHS Trusts submitting data (133/156) 36,504 admissions 70%
More informationDetailed Order Request Checklists for Cardiology
Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018
More informationUniversity of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CCU Rotation Goals and Objectives Goals
Goals Learn to coordinate a variety of data from multiple cardiovascular sub-disciplines, e.g. catheterization laboratory, hemodynamic study, non-invasive imaging, nuclear, electrophysiologic, and in combination
More informationCoronary Heart Disease. Iqbal Malik
Coronary Heart Disease Iqbal Malik Pathophysiology IHD Case chest pain Question -interactive What is the result of the exercise test? 1. negative 2. positive 3. equivocal 4. other Q2 answer STEMI! What
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:
More informationHeart Failure with Preserved EF (HFPEF) Epidemiology and management
Heart Failure with Preserved EF (HFPEF) Epidemiology and management Karl Swedberg Senior Professor of Medicine Sahlgrenska Academy University of Gothenburg Gothenburg, Sweden e-mail: karl.swedberg@gu.se
More informationUpdate on Palpitations and AF February 28 th 2018
Update on Palpitations and AF February 28 th 2018 Dr Mrinal Andrew Saha MA(Cantab) MBBS FRCP PhD Consultant Interventional Cardiologist GHNHSFT Dr Mrinal Saha Appointed 2010 Special interests: Angioplasty,
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationChest Pain. Dr Robert Huggett Consultant Cardiologist
Chest Pain Dr Robert Huggett Consultant Cardiologist Outline Diagnosis of cardiac chest pain 2016 NICE update on stable chest pain Assessment of unstable chest pain/acs and MI definition Scope of the
More informationUnderstanding the guidelines for Interventions in MR. Ali AlMasood
Understanding the guidelines for Interventions in MR Ali AlMasood Mitral regurgitation The most diverse from all acquired valve diseases About 50% of patients with an LVEF 35 percent had moderate to severe
More informationSummary Protocol ISRCTN / NCT REVIVED-BCIS2 Summary protocol version 4, May 2015 Page 1 of 6
Summary Protocol REVIVED-BCIS2 Summary protocol version 4, May 2015 Page 1 of 6 Background: Epidemiology In 2002, it was estimated that approximately 900,000 individuals in the United Kingdom had a diagnosis
More informationNT-proBNP: Evidence-based application in primary care
NT-proBNP: Evidence-based application in primary care Associate Professor Rob Doughty The University of Auckland, Auckland City Hospital, Auckland Heart Group NT-proBNP: Evidence in Primary Care The problem
More informationPerioperative Cardiovascular Evaluation and Care for Noncardiac. Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30
Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30 Active Cardiac Conditions for Which the Patient Should Undergo Evaluation
More informationManagement of Arrhythmias The General Practitioners role
Management of Arrhythmias The General Practitioners role Rohan Gunawardena MD, FRCP, FCCP, FACC Consultant Cardiac Electrophysiologist National Hospital of Sri Lanka Arrhythmias not common Palpitations
More informationList of Workshops Workshop Title
List of Workshops 2017 Year 2017 A CANADIAN HEART RHYTHM SOCIETY WORKSHOP: MANAGEMENT OF VENTRICULAR TACHYCARDIA 2017 CANADIAN SOCIETY OF CARDIOVASCULAR NUCLEAR AND CT IMAGING: CORONARY ATHEROSCLEROSIS
More informationAortic Valve Practice Guidelines: What Has Changed and What You Need to Know
Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts
More informationUnnecessary hospitalisation and investigation of low risk patients presenting to hospital with chest pain
Unnecessary hospitalisation and investigation of low risk patients presenting to hospital with chest pain Michael Perera Advanced Trainee in General and Acute Medicine Leena Aggarwal Director, Medical
More informationΜαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό
Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Diastolic HF DD: Diastolic Dysfunction DHF: Diastolic HF HFpEF: HF with preserved EF DD Pathophysiologic condition: impaired relaxation, LV compliance, LV filling
More information8:30-10:30 WS #4: Cardiology :00-13:00 WS #11: Cardiology 101 (Repeated)
Professor Ralph Stewart Cardiologist Auckland City Hospital Green Lane Cardiovascular Research Unit Auckland Heart Group Fiona Stewart Cardiologist Green Lane Hospital National Women's Hospital Professor
More informationA new option for the Diagnosis and Management of Valvular Heart Disease. Oregon Comprehensive Valve Center
A new option for the Diagnosis and Management of Valvular Heart Disease Oregon Comprehensive Valve Center I have no disclosures Oregon Comprehensive Valve Center Weekly multidisciplinary case conferences
More informationHeart Failure. GP Update Refresher 18 th January 2018
GP Update Refresher 18 th January 2018 Heart Failure Dr. Alexander Lyon Senior Lecturer and Consultant Cardiologist Clinical Lead in Cardio-Oncology Royal Brompton Hospital, London UK President of British
More informationPRE Operative Care of the High Risk Surgical Patient. Dr A T Dewhurst Consultant Anaesthetist St George s Hospital London
PRE Operative Care of the High Risk Surgical Patient Dr A T Dewhurst Consultant Anaesthetist St George s Hospital London Perioperative Optimization Shoemaker oxygen delivery goal directed therapy ITS NOT
More informationSusan P. D Anna MSN, APRN BC February 14, 2019
Is there Equal Opportunity in Heart Failure?? Susan P. D Anna MSN, APRN BC February 14, 2019 Disclosures: I have no financial disclosures. I am not an expert on this topic, but see a lot of women with
More informationThe new Guidelines: Focus on Chronic Heart Failure
The new Guidelines: Focus on Chronic Heart Failure Petros Nihoyannopoulos MD, FRCP, FESC Professor of Cardiology Imperial College London and National & Kapodistrian University of Athens 2 3 4 The principal
More informationHeart Failure from a GP perspective
Heart Failure from a GP perspective Jane Gilmour, Alison Wright Clinical Nurse Specialists for Heart Failure The Heart failure Team Dr Ganesan Kumar- Consultant Cardiologist Dr D Maras- Staff Grade Cardiology
More informationHEART FAILURE. Study day November 2017 Sarah Briggs and Janet Laing
HEART FAILURE Study day November 2017 Sarah Briggs and Janet Laing Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology
More informationCardiology. Presented by: Dr Paul Bethell GP Lead for Planned Care
Cardiology Presented by: Dr Paul Bethell GP Lead for Planned Care 16 th April 2015 Integrated Cardiology Service for Ipswich and East Suffolk CCG IHT 6 consultants - all with specialist areas PCI CoW rapid
More informationAtrial Fibrillation. A guide for Southwark General Practice. Key Messages. Always work within your knowledge and competency
Atrial Fibrillation A guide for Southwark General Practice Key Messages 1. Routinely offer pulse checks to patients at high risk of AF 2. Use the CHA 2 DS 2 VASc score to identify patients for anticoagulation
More informationHeart Failure. A Marvellous Story with More to Come. Prof Ken McDonald National Clinical Lead for Heart Failure
Heart Failure A Marvellous Story with More to Come Prof Ken McDonald National Clinical Lead for Heart Failure Advances in Heart Failure over Last 20 years Pharmacotherapy in HF-REF ADHF 50-15% Community
More informationQuality Payment Program: Cardiology Specialty Measure Set
Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for
More informationAtrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation
Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation ANIL K. BHANDARI, M.D, Director, Electrophysiology and EPS Fellowship Program Good Samaritan Hospital/ Harbor UCLA
More informationMedical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI
Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationAdvanced Heart Failure Management. Dr Andrew Hannah Consultant Cardiologist Aberdeen Royal Infirmary
Advanced Heart Failure Management Dr Andrew Hannah Consultant Cardiologist Aberdeen Royal Infirmary Grading of heart failure Mr WY age 73 3/12 dyspnoea, fatigue and some ankle oedema PMH: hypertension
More informationThe Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician
The Atrial Fibrillation Clinic in Llanelli Dr Lena Marie Izzat Consultant Cardiovascular Physician Llanelli Multidisciplinary AF Clinic Went live January 2009 Based on the fact that Carmarthenshire has
More informationProof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government
Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease Produced on behalf of NHS Wales and Welsh Government April 2018 Table of Contents Introduction... 3 Variation in health services...
More informationThe ACC Heart Failure Guidelines
The ACC Heart Failure Guidelines Fakhr Alayoubi, Msc,R Ph President of SCCP Cardiology Clinical Pharmacist Assistant Professor At King Saud University King Khalid University Hospital Riyadh-KSA 2017 ACC/AHA/HFSA
More informationST-elevation myocardial infarctions (STEMIs)
Guidelines for Treating STEMI: Case-Based Questions As many as 25% of eligible patients presenting with STEMI do not receive any form of reperfusion therapy. The ACC/AHA guidelines highlight steps to improve
More informationHeart Failure (HF) - Primary Care Flow Charts. Pre diagnosis Symptoms or signs suggestive of HF
Heart Failure (HF) - Primary Care Flow Charts Pre diagnosis Symptoms or signs suggestive of HF 12 lead ECG Normal examination and 12 lead ECG HF highly unlikely Abnormal 12 lead ECG HF Possible Arrange
More informationHeart Failure (HF) - Primary Care Flow Charts. Symptoms or signs suggestive of HF. Pre diagnosis. Refer to the Heart Failure Clinic at VHK for
Heart Failure (HF) - Primary Care Flow Charts Pre diagnosis Symptoms or signs suggestive of HF 12 lead ECG Normal examination and 12 lead ECG HF highly unlikely Abnormal 12 lead ECG HF Possible Arrange
More informationHFpEF. April 26, 2018
HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes
More informationTHE HEART OF THE MATTER MAYANNA LUND CMH
THE HEART OF THE MATTER MAYANNA LUND CMH CARDIOLOGY ASSESSMENT AND WHEN TO REFER CHEST PAIN - ACUTE History Examination: vital signs are vital ECG Troponin Concerns: MI, unstable angina, PE, aortic dissection
More information9/2/2016 CARDIOLOGY TESTING WHAT TO ORDER WHEN REFERENCE OBJECTIVES
CARDIOLOGY TESTING WHAT TO ORDER WHEN A J W A D F A R A H, M S, P A - C A S S O C I A T E D I R E C T O R O F M E D I C A L O P E R A T I O N S O F A D V A N C E D P R A C T I C E P R O V I D E R S W I
More informationCardiology when to refer
when to refer Referral criteria are never absolute but some essential guidelines can be found here. PATRICK COMMERFORD, MB ChB, FCP (SA) Professor of Cardiology, Department of Medicine, University of Cape
More informationTherapeutic Targets and Interventions
Therapeutic Targets and Interventions Ali Valika, MD, FACC Advanced Heart Failure and Pulmonary Hypertension Advocate Medical Group Midwest Heart Foundation Disclosures: 1. Novartis: Speaker Honorarium
More informationTreatment strategy decision tree
strategy decision tree strategy decision tree Confirmed diagnosis of AF Further investigations and clinical assessment including risk stratification for stroke/thromboembolism Paroxysmal AF Persistent
More informationNICE Chronic Heart Failure Guidelines in Adults 2018
NICE Chronic Heart Failure Guidelines in Adults 2018 The Whys, Whats and Hows of the importance of effectively managing heart failure in Primary Care and the community. Foreword Dr Clare J Taylor, General
More informationCardiology The interface between Primary and Secondary Care
Cardiology The interface between Primary and Secondary Care Dr A Daniels GP, Cardiff South East Wales Cardiac Network The view from secondary care Referral to treatment times targets Clinics are full of
More informationInnovation therapy in Heart Failure
Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure
More informationThe NEW Heart Failure Guidelines
The NEW Heart Failure Guidelines Daily Practice HF scenario of the Case Presentations HF as a complex and heterogeneous syndrome Several proposed pathophysiological mechanisms involving the heart and the
More informationQuality Payment Program: Cardiology Specialty Measure Set
Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor
More informationHEART FAILURE. Study day November 2018 Sarah Briggs
HEART FAILURE Study day November 2018 Sarah Briggs Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology of heart failure
More informationReview guidance for patients on long-term amiodarone treatment
Review guidance for patients on long-term amiodarone treatment This review guidance document has been produced in response to: 1. Current supply shortages of branded and generic versions of 100mg and 200mg
More informationAccepted Manuscript. S (16) /j.amjcard Reference: AJC To appear in: The American Journal of Cardiology
Accepted Manuscript Referral for Specialist Follow-Up and its Association with Post-Discharge Mortality among Patients with Systolic Heart Failure (From the National Heart Failure Audit for England & Wales)
More informationValvular Heart Disease Mitral Stenosis
Valvular Heart Disease Mitral Stenosis A 75 year old woman with loud first heart sound and mid-diastolic murmur Chronic dyspnea Class 2/4 Fatigue Recent orthopnea/pnd Nocturnal palpitation Pedal edema
More informationTreatment of Hypertrophic Cardiomyopathy in Bruce B. Reid, MD
Treatment of Hypertrophic Cardiomyopathy in 2017 Bruce B. Reid, MD Disclosures I have no conflicts of interest to disclose I will not be discussing any off label medications and/or devices Objectives 1)
More informationHeart Failure. Optimising treatment and balancing co-morbidity in the community. Andrew Ludman Cardiologist
Heart Failure Optimising treatment and balancing co-morbidity in the community Andrew Ludman Cardiologist What is heart failure? A structural cardiac abnormality leading to failure of the heart to provide
More informationBeta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National
More informationAF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management
AF in the ER: Common Scenarios Atrial fibrillation is a common problem with a wide spectrum of presentations. Below are five common emergency room scenarios and the management strategies for each. Evan
More informationAntony French Consultant Cardiologist & Electrophysiologist
Antony French Consultant Cardiologist & Electrophysiologist Palpitations Unpleasant awareness of rapid or forceful heart beat Not all tachycardias cause palpitations, and not all palpitations are due to
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationManagement of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39
Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often
More informationMITRAL REGURGITATION REFERRAL TOOLKIT
1. Patient Case Summary Worksheets Use these checklists to help collect all necessary patient information. Initial echocardiogram MR symptoms and related conditions Patient conditions that may impact therapy
More informationAcute Coronary Syndrome. Sonny Achtchi, DO
Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification
More informationTEACH & TREAT Post-Myocardial Infarction Left Ventricular Systolic Dysfunction
TEACH & TREAT Post-Myocardial Infarction Left Ventricular Systolic Dysfunction Clare Murphy, Paul Forsyth, Steve McGlynn, Margaret Ryan, Anne Watson, Lynsey Moir, Iain Speirits, Mark Petrie, Ninian Lang,
More informationAtrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018
Atrial Fibrillation and the NOAC s John Raymond MS, PA-C, MHP February 10, 2018 Pathogenesis EPIDEMIOLOGY Arrhythmia-related hospitalisations in the US Ventricular fibrillation 2% Atrial fibrillation 34%
More informationCatheter-based mitral valve repair MitraClip System
Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular
More informationEnhancing the Quality of Heart Failure Care
Enhancing the Quality of Heart Failure Care 2 Enhancing the quality of Heart Failure care Kent Surrey Sussex Academic Health Science Network 3 Contents 2 Heart failure care in the UK: Case for change 3
More informationAtrial Fibrillation Cases. Dr Paul Broadhurst Consultant Cardiologist
Atrial Fibrillation Cases Dr Paul Broadhurst Consultant Cardiologist November 2011 Mr TH age 72 Routine medical for hypertension check Denies any symptoms despite close questioning PMH: hypertension, MI,
More informationManagement of new-onset AF: Initial rate control treatment
Geneva Acute Crdiovascular Care Congress 2014 - October 18-20, 2014 Management of new-onset AF: Initial rate control treatment Antonio Raviele, MD, FESC, FHRS ALFA Alliance to Fight Atrial fibrillation,
More informationC1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders
C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders GENERAL ISSUES REGARDING MEDICAL FITNESS-FOR-DUTY 1. These medical standards apply to Union Pacific Railroad (UPRR) employees
More informationAcute Coronary Syndromes: Challenges to Management. Claire Williams November 2017
Acute Coronary Syndromes: Challenges to Management Claire Williams November 2017 Challenge 1: Diagnosis Chest pain >20 minutes ECG Challenge 1: Diagnosis Treat as STEMI Chest pain >20 minutes ECG STEMI
More informationUniversity of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives
Background: The field of critical care cardiology has evolved considerably over the past 2 decades. Contemporary critical care cardiology is increasingly focused on the management of patients with advanced
More informationOptions for my no option Patients Treating Heart Conditions Via a Tiny Catheter
Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter Nirat Beohar, MD Associate Professor of Medicine Director Cardiac Catheterization Laboratory, Medical Director Structural
More information